Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-02

Clinical Trial Update: Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating doxycycline versus placebo for severe nonproliferative or mild/moderate proliferative diabetic retinopathy has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)

Snippet

Sponsor: Thomas Gardner | Conditions: Diabetic Retinopathy | Phase 2 | Status: COMPLETED | Results posted: 2018-11-02